Gordon C. Tucker
Papers
1
Total Citations
3
H-Index
1
About
Gordon C. Tucker is a medicinal chemist whose work has advanced the discovery of enzyme inhibitors through innovative combinatorial chemistry. His research focuses on the design and synthesis of peptide libraries and their deconvolution into potent, nonpeptide lead compounds. In a landmark 2001 study, Tucker and his team synthesized a complete 331,776-member library of tetrapeptides on solid phase, using 24 amino acid building blocks. By systematically deconvoluting sublibraries based on inhibitory potency in an HPLC-based in vitro assay of S-farnesyltransferase, they identified optimized nonpeptide ligands with enhanced activity. This work demonstrated a powerful, high-throughput strategy for transforming complex peptide mixtures into drug-like molecules, bridging the gap between library screening and rational design. Though his most cited paper has garnered 3 citations, Tucker’s contributions are valued for their methodological rigor and impact on early-stage drug discovery. His approach has influenced subsequent efforts in targeting protein prenylation, a key pathway in cancer biology.
Research Focus
Key Achievements
Top Papers
- 1